Filing Details
- Accession Number:
- 0001199719-22-000064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-22 13:21:38
- Reporting Period:
- 2022-08-19
- Accepted Time:
- 2022-08-22 13:21:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
883241 | Synopsys Inc | SNPS | Services-Prepackaged Software (7372) | 561546236 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1373606 | W Joseph Logan | 690 East Middlefield Road Mountain View CA 94043 | Chief Revenue Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-19 | 35,274 | $89.76 | 135,181 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-08-19 | 35,274 | $364.43 | 99,907 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-08-19 | 35,274 | $0.00 | 35,274 | $89.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,758 | 2019-12-12 | 2025-12-12 | No | 4 | M | Direct |
Footnotes
- Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $361.92 to $368.87. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.